Navigating the Post-BCMA/GPRC5D Landscape: Efficacy of Selinexor, Bortezomib, and Dexamethasone After Sequential Immunotherapy Failure in Penta-Refractory Multiple Myeloma-A Multicenter Analysis
Al-Bazaz M, Alsdorf W, Leypoldt L, Sonnemann P, Schaefers C, Artzenroth J, Harzer M, Kamili A, Bartke L, Cords L, Vorwerk J, Leitner T, Maulhardt M, Brinkert K, Brioli A, Richardson T, Holtick U, Hillmann S, Salwender H, Khandanpour C, Bokemeyer C, Weisel K, Kosch R
AM J HEMATOL. 2026;101(7):1433-1439.

Hepatitis E virus infections in people with multiple myeloma an emerging challenge in the era of immunotherapeutic approaches
Al-Bazaz M, Pischke S, Alsdorf W, Sonnemann P, Cichutek S, Wiesch J, Schaefers C, Artzenroth J, Leypoldt L, Kamili A, Bokemeyer C, Weisel K, Kosch R
HAEMATOLOGICA. 2026;111(3):1017-1028.

Characteristics, treatment regimens, and outcomes of patients with true extramedullary multiple myeloma: a real-world monocentric analysis
Harzer M, Gross-Fengels N, Melzer F, Molwitz I, Kosch R, Al-Bazaz M, Artzenroth J, Cords L, Bartke L, Kamili A, Alsdorf W, Bokemeyer C, Weisel K, Leypoldt L, Schaefers C
ANN HEMATOL. 2026;105(7):.

Malignancy-Associated Hemophagocytic Lymphohistiocytosis: Clinical Characteristics, Treatment Patterns, and Survival Outcomes in a Tertiary Care Center Cohort
Kosch R, Alsdorf W, Ahmadi P, Hölzemer A, Abdelrahim A, Ahrens K, Bokemeyer C, Weisel K, Sonnemann P, Al-Bazaz M
CL LYMPH MYELOM LEUK. 2026 [Epub ahead of print].

Acute Lymphoblastic Leukemia Characterized by Rare BCR:FGFR1 Translocation: A Case Report With Literature Review.
Al-Bazaz M, Forstreuter A, Hammada I, Hille J, Wagner J, Reinert J, Wehrhahn J, Bokemeyer C, Fiedler W
CASE REP HEMATOL. 2025;2025(1):.

53/w mit Kurzatmigkeit, Herzklopfen und Ikterus
Al-Bazaz M, Weisel K, Voigtländer M
ONKOLOGIE-GER. 2025;31(1 Suppl):39-44.

Activity of CAR-T cells and bispecific antibodies in multiple myeloma with extramedullary involvement
Steinhardt M, Schaefers C, Leypoldt L, Blau I, Harzer M, Zhou X, Riedhammer C, Kamili A, Kosch R, Topp L, Molwitz I, Gross-Fengels N, Melzer Y, Artzenroth J, Al-Bazaz M, Alsdorf W, Topp M, Duell J, Mersi J, Waldschmidt J, Bokemeyer C, Einsele H, Kortüm K, Weisel K, Rasche L
BLOOD CANCER J. 2025;15(1):126.

Correction: Activity of CAR-T cells and bispecific antibodies in multiple myeloma with extramedullary involvement
Steinhardt M, Schaefers C, Leypoldt L, Blau I, Harzer M, Zhou X, Riedhammer C, Kamili A, Kosch R, Topp L, Molwitz I, Gross-Fengels N, Melzer Y, Artzenroth J, Al-Bazaz M, Alsdorf W, Topp M, Duell J, Mersi J, Waldschmidt J, Bokemeyer C, Einsele H, Kortüm K, Weisel K, Rasche L
BLOOD CANCER J. 2025;15(1):.

Case Report of a DDX41 Germline Mutation in a Family with Multiple Relatives Suffering from Leukemia
Wagner J, Al-Bazaz M, Forstreuter A, Hammada M, Hille J, Papingi D, Bokemeyer C, Fiedler W
BIOMEDICINES. 2023;12(1):.

Letzte Aktualisierung aus dem FIS: 22.07.2026 - 05:16 Uhr